eNauka - pregled
Pregled prema Projekat Genentech
Prikaz rezultata 1 do 11 od 11
Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
---|---|---|---|---|
2012 | A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate | Mease, P; Strand, Vibeke; Shalamberidze, L; Dimic, Aleksandar N; Raskina, T; Xu, Li-An; Liu, Y; Smith, J | Naučni članak | 21aM21a - Rad u međ. časopisu izuzetnih vrednosti |
2020 | Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC | Herbst, Roy S; ...; Andric, Zoran G; ...; (broj, koautora 22) | Naučni članak | 21aM21a - Rad u međ. časopisu izuzetnih vrednosti |
2015 | Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents | Karmiris, Konstantinos; ...; Tarabar, Dino K; ...; (broj, koautora 20) | Naučni članak | 21M21 - Rad u vrhunskom međ. časopisu |
2022 | Clinical Trial Readiness for Spinal Muscular Atrophy: Experience of an International Educational-Training Initiative | Tizzano, Eduardo F; Christie-Brown, Vanessa; Baranello, Giovanni; Germanenko, Olga; Gray, Allyson; Krstic, Marija; Lilien, Charlotte; Patel, Hinal; Servais, Laurent; Scoto, Mariacristina | Naučni članak | 22M22 - Rad u istaknutom međ. časopisu |
2023 | Comparative study of virulence factor genes, beta-hemolysis and biofilm production in invasive and colonizing enterococci | Jovanovic, Milica M; Velebit, Branko M ![]() ![]() | Naučni članak | 23M23 - Rad u međ. časopisu |
2016 | Efficacy analysis of opicinumab in relapsing multiple sclerosis: the Phase 2b SYNERGY trial. | Cadaviv, Diego; Edwards, KR; Hupperts, Raymond; Drulovic, Jelena S ![]() ![]()
Zhang, Yiwei; Xu, Lei;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2014 | Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis | Davi, Sergio; ...; Susic, Gordana Z; ...; (broj, koautora 43) | Naučni članak | 23M23 - Rad u međ. časopisu |
2020 | Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE). | Rodriguez-Abreu, Delvys; ...; Secen, Nevena M; ...; (broj, koautora 20) | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2016 | Reappraising Immunoglobulin Repertoire Restrictions in Chronic Lymphocytic Leukemia: Focus on Major Stereotyped Subsets and Closely Related Satellites | Agathangelidis, Andreas; Hadzidimitriou, Anastasia; Minga, Eva; Sutton, Lesley-Ann; Polychronidou, Eleftheria; Shanafelt, Tait D.; Davis, Zadie; Yan, Xiao-Jie; Plevova, Karla; Boudjoghra, Myriam;
Navarro, Alba; Rossi, Davide; Pedersen, Lone Bredo; Bikos, Vasilis; Baliakas, Panagiotis; Scarfo, Lydia; Mattsson, Mattias; Xochelli, Aliki; di Celle, Paola Francia; Giannopoulos, Krzysztof; Vanura, Katrina; Evers, Ludo; Veronese, Silvio; Facco, Monica; Moschonas, Panagiotis; Bystry, Vojtech; Karan-Đurašević, Teodora
![]() ![]() ![]() ![]() | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
2022 | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study | Cho, Byoung Chul; ...; Secen, Nevena M; ...; (broj, koautora 19) | Naučni članak | 21aM21a - Rad u međ. časopisu izuzetnih vrednosti |
2021 | Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC | Jassem, Jacek; ...; Andric, Zoran G; ...; (broj, koautora 19) | Naučni članak | 21aM21a - Rad u međ. časopisu izuzetnih vrednosti |